Get the Stockscreener App
12.41
1.82%
-0.23
After Hours:
12.33
-0.08
-0.64%
Septerna Inc stock is traded at $12.41, with a volume of 127.46K.
It is down -1.82% in the last 24 hours and up +17.41% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$12.64
Open:
$12.62
24h Volume:
127.46K
Relative Volume:
0.12
Market Cap:
$552.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.48%
1M Performance:
+17.41%
6M Performance:
-26.61%
1Y Performance:
+0.00%
1-Day Range:
$12.36
$12.77
1-Week Range:
$12.25
$14.21
52-Week Range:
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
12.41 | 563.22M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Initiated | H.C. Wainwright | Buy |
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
View All
Septerna Inc Stock (SEPN) Latest News
How volatile is Septerna Inc. stock compared to the marketBreakout Stocks Insights To Watch Now - jammulinksnews.com
Why is Septerna Inc. stock attracting strong analyst attentionSmart Portfolio Growth Plan For Beginners - jammulinksnews.com
Septerna Inc. stock momentum explainedHigh Conviction Intraday Stock Signals Detected - metal.it
Why Septerna Inc. stock attracts strong analyst attentionEntry Alert Based on Volume Spikes Detected - metal.it
Short Interest Drops in Septerna Inc. After RallyWeekly Top Gainers Forecast Watchlist Released - metal.it
What makes Septerna Inc. stock price move sharplySecure Return Focused Investment Plan Released - metal.it
Septerna Inc. Trading Near Value Zone — Recovery AheadMomentum Based Equity Trading Plans Reviewed - metal.it
What is the dividend policy of Septerna Inc. stockDiscover high-impact stocks for growth - jammulinksnews.com
What catalysts could drive Septerna Inc. stock higher in 2025Free Stock Signals For Fast Growth - jammulinksnews.com
What are the technical indicators suggesting about Septerna Inc.Achieve breakthrough profits with expert advice - jammulinksnews.com
Is it the right time to buy Septerna Inc. stockExponential return rates - jammulinksnews.com
What markets is Septerna Inc. expanding into Is BACQ stock a good long term investment optionFree Smart Trading Workshop - jammulinksnews.com
What markets is MUFG expanding into Is Septerna Inc. stock a good long term investment optionAchieve rapid portfolio appreciation - jammulinksnews.com
What are the latest earnings results for Septerna Inc.Achieve rapid portfolio appreciation today - jammulinksnews.com
How high can Septerna Inc. stock price go in 2025Free Stock Market Real-Time Monitoring - jammulinksnews.com
What analysts say about Septerna Inc. stockTremendous growth opportunities - PrintWeekIndia
What drives Septerna Inc. stock priceStrong return on investment - PrintWeekIndia
We Think Septerna (NASDAQ:SEPN) Can Easily Afford To Drive Business Growth - 富途牛牛
Is Septerna Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Septerna Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - jammulinksnews.com
Septerna Insiders Enjoying US$951k Appreciation On US$934.3k Investment - simplywall.st
How Septerna Inc. stock performs during market volatilityFast Gains With Reduced Risk - beatles.ru
Novo Nordisk taps Septerna in $2.2bn deal for oral obesity therapies - MSN
Septerna Inc Stock (SEPN) Financials Data
There is no financial data for Septerna Inc (SEPN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):